MINNEAPOLIS, Jan. 2, 2024 /PRNewswire/ — Norway-based CardioMech AS, a medical device company developing a transfemoral, transseptally delivered mitral valve chordal repair technology in Fridley, MN, today announced it has closed on $13M in fresh capital ($42M to-date). CardioMech received strong financial support from existing and new investors, including a non-disclosed strategic investor. The heavily oversubscribed round […]

The Series A, led by a non-disclosed strategic investor, together with Hadean Ventures and Investinor, will fund CardioMech’s journey to treat patients in a first-in-human feasibility trial MINNEAPOLIS, Aug. 5, 2020 /PRNewswire/ — Minneapolis based CardioMech AS, a medical device company developing a transfemoral, transseptally delivered mitral valve repair technology, announced today it […]

OSLO–(BUSINESS WIRE)–CardioMech AS announced today that it has closed on a convertible note financing of $2.5 million, which was significantly oversubscribed. The note included investments from experienced angel investors in interventional cardiology and structural heart disease. “This financing milestone demonstrates the rapid acceleration of the development of CardioMech’s transcatheter mitral valve repair technology. […]

TRONDHEIM, Norway–(BUSINESS WIRE)–CardioMech AS announced today that it has appointed Richard Nehm as President and CEO, and Mark Novotny as Chairman of the Board of Directors, effective immediately. Rick and Mark join the company alongside founders Jacob Bergsland, Chief Medical Officer, and Nikolai Hiorth, Chief Technology Officer. Rick Nehm is a seasoned medical device professional in the […]